Kingfisher Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.15M Buy
11,036
+156
+1% +$15.9K 0.26% 90
2024
Q2
$1.06M Buy
10,880
+34
+0.3% +$3.14K 0.25% 91
2024
Q1
$977K Buy
10,846
+37
+0.3% +$3.13K 0.24% 91
2023
Q4
$862K Buy
10,809
+40
+0.4% +$3.01K 0.22% 96
2023
Q3
$766K Buy
10,769
+41
+0.4% +$3.07K 0.21% 99
2023
Q2
$826K Sell
10,728
-203
-2% -$15.7K 0.22% 101
2023
Q1
$821K Buy
10,931
+43
+0.4% +$3.2K 0.22% 98
2022
Q4
$858K Buy
10,888
+40
+0.4% +$3K 0.23% 100
2022
Q3
$762K Buy
10,848
+3,512
+48% +$275K 0.21% 105
2022
Q2
$588K Sell
7,336
-118
-2% -$9.23K 0.17% 119
2022
Q1
$565K Buy
7,454
+37
+0.5% +$2.93K 0.15% 127
2021
Q4
$633K Buy
7,417
+38
+0.5% +$2.97K 0.15% 132
2021
Q3
$557K Buy
7,379
+36
+0.5% +$2.86K 0.14% 129
2021
Q2
$597K Buy
7,343
+19
+0.3% +$1.55K 0.15% 133
2021
Q1
$577K Buy
7,324
+53
+0.7% +$4.15K 0.16% 130
2020
Q4
$622K Buy
7,271
+33
+0.5% +$2.73K 0.19% 121
2020
Q3
$558K Buy
7,238
+36
+0.5% +$2.75K 0.2% 116
2020
Q2
$528K Buy
7,202
+753
+12% +$53.5K 0.23% 104
2020
Q1
$428K Sell
6,449
-219
-3% -$15.4K 0.22% 110
2019
Q4
$459K Buy
6,668
+42
+0.6% +$2.86K 0.21% 117
2019
Q3
$487K Buy
6,626
+38
+0.6% +$2.76K 0.29% 101
2019
Q2
$472K Buy
6,588
+37
+0.6% +$2.63K 0.29% 88
2019
Q1
$449K Sell
6,551
-317
-5% -$20.5K 0.29% 89
2018
Q4
$409K Sell
6,868
-125
-2% -$7.82K 0.29% 91
2018
Q3
$468K Buy
6,993
+9
+0.1% +$599 0.25% 95
2018
Q2
$453K Sell
6,984
-231
-3% -$15.1K 0.29% 94
2018
Q1
$517K Buy
7,215
+34
+0.5% +$2.45K 0.33% 90
2017
Q4
$542K Buy
7,181
+9
+0.1% +$657 0.34% 88
2017
Q3
$522K Buy
7,172
+37
+0.5% +$2.67K 0.35% 86
2017
Q2
$529K Buy
7,135
+1
+0% +$74 0.36% 83
2017
Q1
$522K Buy
7,134
+1
+0% +$70 0.38% 85
2016
Q4
$467K Sell
7,133
-17,196
-71% -$1.18M 0.35% 90
2016
Q3
$1.8M Sell
24,329
-804
-3% -$59.4K 1.26% 22
2016
Q2
$1.84M Sell
25,133
-2,015
-7% -$143K 1.21% 28
2016
Q1
$1.92M Buy
27,148
+368
+1% +$24.5K 1.2% 24
2015
Q4
$1.78M Buy
26,780
+17,598
+192% +$1.17M 1.05% 31
2015
Q3
$583K Buy
9,182
+32
+0.3% +$2.09K 0.37% 95
2015
Q2
$599K Buy
9,150
+4
+0% +$271 0.35% 100
2015
Q1
$634K Hold
9,146
0.33% 106
2014
Q4
$633K Sell
9,146
-50
-0.5% -$3.38K 0.32% 110
2014
Q3
$600K Sell
9,196
-50
-0.5% -$3.3K 0.32% 113
2014
Q2
$630K Hold
9,246
0.33% 115
2014
Q1
$600K Sell
9,246
-100
-1% -$6.3K 0.32% 113
2013
Q4
$609K Sell
9,346
-350
-4% -$22.4K 0.33% 103
2013
Q3
$575K Hold
9,696
0.29% 108
2013
Q2
$555K Buy
+9,696
New +$576K 0.3% 105

Other funds holding CL

Kingfisher Capital's CL Position: Q3 2024 in Review

Kingfisher Capital increased its Colgate-Palmolive (CL) stake by 1.4% in Q3 2024, buying an estimated $15.9K and bringing the position to 11,036 shares worth $1.15M. The position accounts for 0.26% of the portfolio, ranked #90.

Kingfisher Capital first reported a position in CL in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.92M in Q1 2016. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • Kingfisher Capital held 11,036 shares of Colgate-Palmolive worth $1.15M as of Q3 2024.
  • Kingfisher Capital bought 156 Colgate-Palmolive shares in Q3 2024, an estimated $15.9K.
  • Colgate-Palmolive made up 0.26% of Kingfisher Capital's portfolio in Q3 2024, its #90 holding.
  • Kingfisher Capital first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 46 quarters since.
  • Kingfisher Capital's Colgate-Palmolive position peaked at $1.92M in Q1 2016.
  • 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Kingfisher Capital's 13F filing for Q3 2024, filed 14 Nov 2024.